Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)

Autoři	SKŘIČKOVÁ Jana BORTLÍČEK Zbyněk HEJDUK Karel PEŠEK M. KOLEK V. KOUBKOVÁ L. TOMÍŠKOVÁ Marcela ROUBEC J. ZATLOUKAL P. SALAJKA F.
Rok publikování	2012
Druh	Konferenční abstrakty
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Přiložené soubory	Skrickovlung_cancer_006.pdf
Popis	The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients.